Suchergebnisse - "Caraceni, Paolo"

PubPharm (5)

1

Serological response and breakthrough infection after COVID-19 vaccination in patients with cirrhosis and post-liver transplant

enthalten in: Hepatology communications | 2023

von Mehta, G. | Riva, A. | Ballester, M. | +93

2

Serious adverse events with tocilizumab : Pharmacovigilance as an aid to prioritize monitoring in COVID-19

enthalten in: British journal of clinical pharmacology | 2021

von Gatti, M. | Fusaroli, M. | Caraceni, P. | +3

3

Baricitinib, JAK inhibitors and liver injury : a cause for concern in COVID-19?

enthalten in: Expert opinion on drug safety | 2020

von Raschi, E. | Caraceni, P. | Poluzzi, E. | +1

CommentOn: Expert Opin Drug Saf. 2020 Jul 31;:1-7. - PMID 32693646

4

A web-based group treatment for patients with alcoholic liver diseases at the time of the COVID-19 pandemic

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2020

von Bossi, M. | Tufoni, M. | Zaccherini, G. | +3

CommentOn: J Hepatol. 2018 Jul;69(1):154-181. - PMID 29628280

5

Baricitinib, JAK inhibitors and liver injury: a cause for concern in COVID-19?

enthalten in: Expert opinion on drug safety | 2020

von Raschi, E. | Caraceni, P. | Poluzzi, E. | +1

1
[1]